Income Statement (TTM)
PolyPeptide Group AG Income Statement shows changes in income and expenses over a period of time. Income Statement data includes Sales and Revenue, Gross Profit, Research and Development (R&D), Selling, General and Administrative Expense (SG&A), Operating Income, Income Tax Expense, Interest Expense, Non-Operating Income, Earnings per Share (EPS), and Shares Outstanding.
All numbers are times 1,000,000 except per share units.
|
2020 12-31 |
2021 03-31 |
2021 06-30 |
2021 09-30 |
2021 12-31 |
2022 03-31 |
2022 06-30 |
2022 09-30 |
2022 12-31 |
2023 03-31 |
2023 06-30 |
2023 09-30 |
2023 12-31 |
2024 03-31 |
2024 06-30 |
2024 09-30 |
2024 12-31 |
2025 03-31 |
2025 06-30 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 224 | 248 | 271 | 277 | 282 | 281 | 281 | 281 | 281 | 280 | 279 | 300 | 320 | 322 | 324 | 330 | 337 | 353 | 369 |
| Change (%) | 10.41 | 9.43 | 2.05 | 2.01 | -0.26 | -0.26 | 0.06 | 0.06 | -0.32 | -0.33 | 7.38 | 6.87 | 0.50 | 0.50 | 2.04 | 2.00 | 4.76 | 4.54 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Cost Of Sales | 151 | 162 | 174 | 178 | 182 | 187 | 192 | 211 | 229 | 248 | 267 | 291 | 316 | 311 | 306 | 303 | 299 | 313 | 327 |
| Change (%) | 7.45 | 6.93 | 2.54 | 2.47 | 2.72 | 2.65 | 9.52 | 8.69 | 8.24 | 7.61 | 9.16 | 8.39 | -1.46 | -1.48 | -1.15 | -1.17 | 4.68 | 4.47 | |
| % of Revenue | 67.37 | 65.56 | 64.07 | 64.37 | 64.66 | 66.60 | 68.54 | 75.02 | 81.50 | 88.50 | 95.54 | 97.13 | 98.51 | 96.59 | 94.68 | 91.72 | 88.87 | 88.80 | 88.74 |
| Gross Operating Profit | 73 | 85 | 97 | 99 | 100 | 94 | 88 | 70 | 52 | 32 | 12 | 9 | 5 | 11 | 17 | 27 | 37 | 40 | 42 |
| Change (%) | 16.53 | 14.19 | 1.19 | 1.17 | -5.73 | -6.07 | -20.55 | -25.87 | -38.04 | -61.39 | -30.81 | -44.54 | 130.19 | 56.56 | 58.96 | 37.09 | 5.38 | 5.10 | |
| % of Revenue | 32.63 | 34.44 | 35.93 | 35.63 | 35.34 | 33.40 | 31.46 | 24.98 | 18.50 | 11.50 | 4.46 | 2.87 | 1.49 | 3.41 | 5.32 | 8.28 | 11.13 | 11.20 | 11.26 |
| SG&A | 28 | 28 | 29 | 31 | 32 | 36 | 40 | 40 | 41 | 40 | 40 | 41 | 42 | 42 | 43 | 44 | 44 | 46 | 49 |
| Change (%) | 1.20 | 1.19 | 6.65 | 6.23 | 11.82 | 10.57 | 0.55 | 0.55 | -0.75 | -0.75 | 1.89 | 1.86 | 1.89 | 1.86 | 1.32 | 1.30 | 5.02 | 4.78 | |
| % of Revenue | 12.49 | 11.45 | 10.58 | 11.06 | 11.52 | 12.91 | 14.32 | 14.39 | 14.46 | 14.40 | 14.34 | 13.60 | 12.96 | 13.14 | 13.32 | 13.23 | 13.14 | 13.17 | 13.20 |
| R&D | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 |
| Change (%) | 3.70 | 3.56 | -0.07 | -0.07 | -1.42 | -1.44 | -4.54 | -4.75 | 3.62 | 3.49 | 4.95 | 4.72 | -10.07 | -11.20 | -3.21 | -3.31 | 20.91 | 17.30 | |
| % of Revenue | 0.58 | 0.55 | 0.52 | 0.51 | 0.50 | 0.49 | 0.49 | 0.46 | 0.44 | 0.46 | 0.48 | 0.47 | 0.46 | 0.41 | 0.36 | 0.34 | 0.33 | 0.38 | 0.42 |
| OpEx | 180 | 190 | 200 | 208 | 215 | 225 | 234 | 251 | 268 | 287 | 305 | 330 | 354 | 351 | 347 | 345 | 343 | 359 | 376 |
| Change (%) | 5.65 | 5.35 | 3.59 | 3.47 | 4.56 | 4.36 | 7.29 | 6.80 | 6.82 | 6.39 | 8.05 | 7.45 | -1.01 | -1.02 | -0.62 | -0.62 | 4.84 | 4.62 | |
| % of Revenue | 80.24 | 76.78 | 73.92 | 75.04 | 76.11 | 79.79 | 83.48 | 89.52 | 95.54 | 102.39 | 109.28 | 109.97 | 110.56 | 108.89 | 107.24 | 104.45 | 101.77 | 101.85 | 101.93 |
| Operating Income | 44 | 57 | 71 | 69 | 67 | 57 | 46 | 29 | 13 | -7 | -26 | -30 | -34 | -29 | -23 | -15 | -6 | -7 | -7 |
| Change (%) | 29.75 | 22.93 | -2.32 | -2.37 | -15.61 | -18.50 | -36.49 | -57.45 | -153.45 | 287.08 | 15.26 | 13.24 | -15.36 | -18.15 | -37.30 | -59.48 | 9.67 | 8.82 | |
| % of Revenue | 19.76 | 23.22 | 26.08 | 24.96 | 23.89 | 20.21 | 16.52 | 10.48 | 4.46 | -2.39 | -9.28 | -9.97 | -10.56 | -8.89 | -7.24 | -4.45 | -1.77 | -1.85 | -1.93 |
| Interest Expense | -3 | -4 | -4 | -3 | -3 | -4 | -4 | -3 | -2 | -3 | -4 | -5 | -6 | -8 | -9 | -16 | -14 | -22 | -31 |
| Change (%) | 5.70 | 5.39 | -11.78 | -13.35 | 24.14 | 19.45 | -18.41 | -38.78 | 51.15 | 33.84 | 15.52 | 15.07 | 34.05 | 25.40 | 67.09 | -12.32 | 59.28 | 39.88 | |
| % of Revenue | -1.48 | -1.41 | -1.36 | -1.18 | -1.00 | -1.25 | -1.49 | -1.22 | -0.74 | -1.13 | -1.52 | -1.63 | -1.76 | -2.34 | -2.92 | -4.78 | -4.11 | -6.25 | -8.36 |
| Net Income | 31 | 40 | 48 | 48 | 47 | 40 | 33 | 20 | 8 | -14 | -37 | -44 | -51 | -40 | -29 | -24 | -20 | -27 | -35 |
| Change (%) | 26.79 | 21.13 | -0.90 | -0.91 | -15.21 | -17.94 | -38.19 | -61.79 | -286.55 | 153.60 | 19.99 | 16.66 | -22.24 | -28.60 | -15.75 | -18.69 | 38.73 | 27.92 | |
| % of Revenue | 13.97 | 16.04 | 17.76 | 17.24 | 16.75 | 14.24 | 11.72 | 7.24 | 2.76 | -5.17 | -13.16 | -14.71 | -16.06 | -12.42 | -8.83 | -7.29 | -5.81 | -7.69 | -9.41 |
Source: Capital IQ
